{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:32:59Z","timestamp":1787643179768,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antibodies against the spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can drive adaptive evolution in immunocompromised patients with chronic infection. Here we longitudinally analyze SARS-CoV-2 sequences in a B cell-depleted, lymphoma patient with chronic, ultimately fatal infection, and identify three mutations in the spike protein that dampen convalescent plasma-mediated neutralization of SARS-CoV-2. Additionally, four mutations emerge in non-spike regions encoding three CD8 T cell epitopes, including one nucleoprotein epitope affected by two mutations. Recognition of each mutant peptide by CD8 T cells from convalescent donors is reduced compared to its ancestral peptide, with additive effects resulting from double mutations. Querying public SARS-CoV-2 sequences shows that these mutations have independently emerged as homoplasies in circulating lineages. Our data thus suggest that potential impacts of CD8 T cells on SARS-CoV-2 mutations, at least in those with humoral immunodeficiency, warrant further investigation to inform on vaccine design.<\/jats:p>","DOI":"10.1038\/s41467-022-32772-5","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T10:02:46Z","timestamp":1663927366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-1340","authenticated-orcid":false,"given":"Elham","family":"Khatamzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-8808","authenticated-orcid":false,"given":"Markus H.","family":"Antwerpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-3037","authenticated-orcid":false,"given":"Johannes Christian","family":"Hellmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Hollaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5544-4595","authenticated-orcid":false,"given":"Anne-Wiebe","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Gaitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weiglein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Georgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2816-6793","authenticated-orcid":false,"given":"Clemens","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-1020","authenticated-orcid":false,"given":"Stephanie-Susanne","family":"Stecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Gruetzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-2332","authenticated-orcid":false,"given":"Helmut","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Leutbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-9248","authenticated-orcid":false,"given":"Sabine","family":"Zange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1370-4114","authenticated-orcid":false,"given":"Philipp","family":"Girl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-7515","authenticated-orcid":false,"given":"Katharina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-7373","authenticated-orcid":false,"given":"Oliver","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-8357","authenticated-orcid":false,"given":"Karl-Peter","family":"Hopfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Stemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-8946","authenticated-orcid":false,"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8756-7821","authenticated-orcid":false,"given":"Roman","family":"W\u00f6lfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-0470","authenticated-orcid":false,"given":"Maximilian","family":"Muenchhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8044-5146","authenticated-orcid":false,"given":"Andreas","family":"Moosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"32772_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"32772_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell 183, 996\u20131012 (2020).","journal-title":"Cell"},{"key":"32772_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.immuni.2021.05.001","volume":"54","author":"HL Dugan","year":"2021","unstructured":"Dugan, H. L. et al. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity 54, 1290\u20131303 (2021).","journal-title":"Immunity"},{"key":"32772_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02940-20","volume":"12","author":"JJ Guthmiller","year":"2021","unstructured":"Guthmiller, J. J. et al. SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike. MBio 12, 1\u201313 (2021).","journal-title":"MBio"},{"key":"32772_CR5","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Rep. Med. 2, 100355 (2021).","journal-title":"Cell Rep. Med."},{"key":"32772_CR6","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen, K. W. et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep. Med. 2, 100354 (2021).","journal-title":"Cell Rep. Med."},{"key":"32772_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181, 1489\u20131501 (2020).","journal-title":"Cell"},{"key":"32772_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"32772_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"32772_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell 183, 158\u2013168.e14 (2020).","journal-title":"Cell"},{"key":"32772_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"32772_CR12","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","volume":"3","author":"D Cromer","year":"2022","unstructured":"Cromer, D. et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe 3, e52\u2013e61 (2022).","journal-title":"Lancet Microbe"},{"key":"32772_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2021","unstructured":"Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 22, 74\u201385 (2021).","journal-title":"Nat. Immunol."},{"key":"32772_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","volume":"590","author":"K McMahan","year":"2021","unstructured":"McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590, 630\u2013634 (2021).","journal-title":"Nature"},{"key":"32772_CR15","doi-asserted-by":"crossref","unstructured":"Zhuang, Z. et al. Mapping and role of T cell response in SARS-CoV-2-infected mice. J. Exp. Med. 218, (2021).","DOI":"10.1084\/jem.20202187"},{"key":"32772_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","volume":"54","author":"THO Nguyen","year":"2021","unstructured":"Nguyen, T. H. O. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity 54, 1066\u20131082.e5 (2021).","journal-title":"Immunity"},{"key":"32772_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. An immunodominant NP105\u2013113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 23, 50\u201361 (2022).","journal-title":"Nat. Immunol."},{"key":"32772_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41577-022-00716-1","volume":"22","author":"SJ Kent","year":"2022","unstructured":"Kent, S. J. et al. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? Nat. Rev. Immunol. 22, 387\u2013397 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"32772_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27202-x","volume":"12","author":"FP Lyngse","year":"2021","unstructured":"Lyngse, F. P. et al. Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load. Nat. Commun. 12, 7251 (2021).","journal-title":"Nat. Commun."},{"key":"32772_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","volume":"593","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 593, 270\u2013274 (2021).","journal-title":"Nature"},{"key":"32772_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"32772_CR22","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1056\/NEJMc2103740","volume":"384","author":"X Shen","year":"2021","unstructured":"Shen, X. et al. Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351. N. Engl. J. Med. 384, 2352\u20132354 (2021).","journal-title":"N. Engl. J. Med."},{"key":"32772_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas, D. et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596, 276\u2013280 (2021).","journal-title":"Nature"},{"key":"32772_CR24","doi-asserted-by":"publisher","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-022-01143-7 (2022).","DOI":"10.1038\/s41564-022-01143-7"},{"key":"32772_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1056\/NEJMc2200133","volume":"386","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh, H. N. et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N. Engl. J. Med. 386, 1288\u20131290 (2022).","journal-title":"N. Engl. J. Med."},{"key":"32772_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"32772_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJMc2206576","volume":"387","author":"NP Hachmann","year":"2022","unstructured":"Hachmann, N. P. et al. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N. Engl. J. Med. 387, 86\u201388 (2022).","journal-title":"N. Engl. J. Med."},{"key":"32772_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","volume":"28","author":"PR Wratil","year":"2022","unstructured":"Wratil, P. R. et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat. Med. 28, 496\u2013503 (2022).","journal-title":"Nat. Med."},{"key":"32772_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"32772_CR30","first-page":"567","volume":"362","author":"L Corey","year":"2011","unstructured":"Corey, L. et al. SARS-CoV-2 Variants in Patients with Immunosuppression. N. Engl. J. Med. 362, 567\u2013571 (2011).","journal-title":"N. Engl. J. Med."},{"key":"32772_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1183\/13993003.01190-2020","volume":"56","author":"Y Fu","year":"2020","unstructured":"Fu, Y. et al. Risk factors for viral RNA shedding in COVID-19 patients. Eur. Respir. J. 56, 2\u20134 (2020).","journal-title":"Eur. Respir. J."},{"key":"32772_CR32","unstructured":"Lythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science 372, (2021)."},{"key":"32772_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cid\/ciaa863","volume":"72","author":"M Fung","year":"2021","unstructured":"Fung, M. & Babik, J. M. COVID-19 in Immunocompromised Hosts: What We Know so Far. Clin. Infect. Dis. 72, 340\u2013350 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"32772_CR34","doi-asserted-by":"publisher","unstructured":"Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature https:\/\/doi.org\/10.1038\/s41586-021-03291-y (2021).","DOI":"10.1038\/s41586-021-03291-y"},{"key":"32772_CR35","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi, B. et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N. Engl. J. Med. 383, 2291\u20132293 (2020).","journal-title":"N. Engl. J. Med."},{"key":"32772_CR36","doi-asserted-by":"crossref","unstructured":"Harari, S. et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat. Med. 28, (2022).","DOI":"10.1101\/2022.02.17.22270829"},{"key":"32772_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","volume":"30","author":"S Cele","year":"2022","unstructured":"Cele, S. et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe 30, 154\u2013162.e5 (2022).","journal-title":"Cell Host Microbe"},{"key":"32772_CR38","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.lanepe.2021.100164","volume":"8","author":"B Jensen","year":"2021","unstructured":"Jensen, B. et al. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg. Heal. - Eur. 8, 100164 (2021).","journal-title":"Lancet Reg. Heal. - Eur."},{"key":"32772_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSphere.00244-21","volume":"6","author":"V Borges","year":"2021","unstructured":"Borges, V. et al. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma. mSphere 6, 1\u20138 (2021).","journal-title":"mSphere"},{"key":"32772_CR40","doi-asserted-by":"crossref","unstructured":"Truong, T. T. et al. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine 67, (2021).","DOI":"10.1016\/j.ebiom.2021.103355"},{"key":"32772_CR41","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","volume":"27","author":"EM Bange","year":"2021","unstructured":"Bange, E. M. et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat. Med. 27, 1280\u20131289 (2021).","journal-title":"Nat. Med."},{"key":"32772_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","volume":"20","author":"DR Collins","year":"2020","unstructured":"Collins, D. R., Gaiha, G. D. & Walker, B. D. CD8+ T cells in HIV control, cure and prevention. Nat. Rev. Immunol. 20, 471\u2013482 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"32772_CR43","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1084\/jem.20030239","volume":"197","author":"NH Shoukry","year":"2003","unstructured":"Shoukry, N. H. et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197, 1645\u20131655 (2003).","journal-title":"J. Exp. Med."},{"key":"32772_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature14053","volume":"517","author":"K Deng","year":"2015","unstructured":"Deng, K. et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517, 381\u2013385 (2015).","journal-title":"Nature"},{"key":"32772_CR45","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20090378","volume":"206","author":"JF Salazar-Gonzalez","year":"2009","unstructured":"Salazar-Gonzalez, J. F. et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206, 1273\u20131289 (2009).","journal-title":"J. Exp. Med."},{"key":"32772_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhep.2020.09.022","volume":"74","author":"R Thimme","year":"2021","unstructured":"Thimme, R. T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine. J. Hepatol. 74, 220\u2013229 (2021).","journal-title":"J. Hepatol."},{"key":"32772_CR47","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1084\/jem.20050808","volume":"201","author":"DG Bowen","year":"2005","unstructured":"Bowen, D. G. & Walker, C. M. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709\u20131714 (2005).","journal-title":"J. Exp. Med."},{"key":"32772_CR48","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","volume":"183","author":"VA Avanzato","year":"2020","unstructured":"Avanzato, V. A. et al. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer. Cell 183, 1901\u20131912.e9 (2020).","journal-title":"Cell"},{"key":"32772_CR49","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","volume":"184","author":"M McCallum","year":"2021","unstructured":"McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332\u20132347.e16 (2021).","journal-title":"Cell"},{"key":"32772_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.abf6950","volume":"371","author":"KR McCarthy","year":"2021","unstructured":"McCarthy, K. R. et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science 371, 1139\u20131142 (2021).","journal-title":"Science"},{"key":"32772_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","volume":"29","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 29, 477\u2013488.e4 (2021).","journal-title":"Cell Host Microbe"},{"key":"32772_CR52","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","volume":"397","author":"O Abani","year":"2021","unstructured":"Abani, O. et al. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet 397, 2049\u20132059 (2021).","journal-title":"Lancet"},{"key":"32772_CR53","unstructured":"ECDC. SARS-CoV-2 variants of concern as of 4th August 2022. European Centre for Disease Prevention and Control https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern."},{"key":"32772_CR54","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep. Med. 2, 100204 (2021).","journal-title":"Cell Rep. Med."},{"key":"32772_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood.2021013429","volume":"139","author":"JC En\u00dfle","year":"2022","unstructured":"En\u00dfle, J. C. et al. Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma. Blood 139, 137\u2013142 (2022).","journal-title":"Blood"},{"key":"32772_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cei.12682","volume":"182","author":"D C\u00e1rdenas","year":"2015","unstructured":"C\u00e1rdenas, D. et al. Epstein-Barr virus-specific CD8+ T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired. Clin. Exp. Immunol. 182, 173\u2013183 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"32772_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00430-014-0372-z","volume":"204","author":"J Timm","year":"2015","unstructured":"Timm, J. & Walker, C. M. Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections. Med. Microbiol. Immunol. 204, 29\u201338 (2015).","journal-title":"Med. Microbiol. Immunol."},{"key":"32772_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nature07746","volume":"458","author":"Y Kawashima","year":"2009","unstructured":"Kawashima, Y. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458, 641\u2013645 (2009).","journal-title":"Nature"},{"key":"32772_CR59","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood.V97.4.835","volume":"97","author":"S Gottschalk","year":"2001","unstructured":"Gottschalk, S. et al. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with vires-specific CTLs. Blood 97, 835\u2013843 (2001).","journal-title":"Blood"},{"key":"32772_CR60","doi-asserted-by":"publisher","unstructured":"Stanevich, O., Alekseeva, E., Sergeeva, M. & Fadeev, A. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-750741\/v1 (2021).","DOI":"10.21203\/rs.3.rs-750741\/v1"},{"key":"32772_CR61","doi-asserted-by":"crossref","unstructured":"de Silva, T. I. et al. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience 24, (2021).","DOI":"10.2139\/ssrn.3844713"},{"key":"32772_CR62","doi-asserted-by":"publisher","unstructured":"Dolton, G. et al. Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope. Cell 141267 https:\/\/doi.org\/10.1016\/j.cell.2022.07.002 (2022).","DOI":"10.1016\/j.cell.2022.07.002"},{"key":"32772_CR63","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185, 1041\u20131051.e6 (2022).","journal-title":"Cell"},{"key":"32772_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abg6461","volume":"6","author":"B Agerer","year":"2021","unstructured":"Agerer, B. et al. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Sci. Immunol. 6, 1\u201313 (2021).","journal-title":"Sci. Immunol."},{"key":"32772_CR65","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity 53, 1095\u20131107.e3 (2020).","journal-title":"Immunity"},{"key":"32772_CR66","doi-asserted-by":"crossref","unstructured":"Ameres, S. et al. Presentation of an Immunodominant Immediate-Early CD8+ T Cell Epitope Resists Human Cytomegalovirus Immunoevasion. PLoS Pathog. 9, (2013).","DOI":"10.1371\/journal.ppat.1003383"},{"key":"32772_CR67","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980.e17 (2021).","journal-title":"Cell"},{"key":"32772_CR68","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm992","volume":"10","author":"AJ Leslie","year":"2004","unstructured":"Leslie, A. J. et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10, 282\u2013289 (2004).","journal-title":"Nat. Med."},{"key":"32772_CR69","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20050121","volume":"201","author":"AL Cox","year":"2005","unstructured":"Cox, A. L. et al. Cellular immune selection with hepatitis C virus persistence in humans. J. Exp. Med. 201, 1741\u20131752 (2005).","journal-title":"J. Exp. Med."},{"key":"32772_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/hep.27771","volume":"62","author":"H Kefalakes","year":"2015","unstructured":"Kefalakes, H. et al. Adaptation of the Hepatitis B Virus Core Protein to CD8+ T-Cell Selection Pressure. Hepatology 62, 47\u201356 (2015).","journal-title":"Hepatology"},{"key":"32772_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.24.2001057","volume":"25","author":"M Muenchhoff","year":"2020","unstructured":"Muenchhoff, M. et al. Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. Eurosurveillance 25, 1\u20135 (2020).","journal-title":"Eurosurveillance"},{"key":"32772_CR72","doi-asserted-by":"crossref","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25, (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"32772_CR73","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1515\/cclm-2020-1183","volume":"58","author":"V Haselmann","year":"2020","unstructured":"Haselmann, V. et al. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing. Clin. Chem. Lab. Med. 58, 2121\u20132130 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"key":"32772_CR74","unstructured":"Garrison, E. & Marth, G. Haplotype-based variant detection from short-read sequencing. ArXiv12073907 Q-Bio (2012)."},{"key":"32772_CR75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly. (Austin). 6, 80\u201392 (2012).","journal-title":"Fly. (Austin)."},{"key":"32772_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1618-7","volume":"20","author":"ND Grubaugh","year":"2019","unstructured":"Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).","journal-title":"Genome Biol."},{"key":"32772_CR77","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"32772_CR78","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield, J. et al. NextStrain: Real-time tracking of pathogen evolution. Bioinformatics 34, 4121\u20134123 (2018).","journal-title":"Bioinformatics"},{"key":"32772_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abf1906","volume":"13","author":"BE Jones","year":"2021","unstructured":"Jones, B. E. et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci. Transl. Med. 13, 1\u201318 (2021).","journal-title":"Sci. Transl. Med."},{"key":"32772_CR80","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369, 650\u2013655 (2020).","journal-title":"Science"},{"key":"32772_CR81","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369, 1010\u20131014 (2020).","journal-title":"Science"},{"key":"32772_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006991","volume":"14","author":"LK Martin","year":"2018","unstructured":"Martin, L. K. et al. Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. PLoS Pathog. 14, 1\u201328 (2018).","journal-title":"PLoS Pathog."},{"key":"32772_CR83","doi-asserted-by":"crossref","unstructured":"Wiesner, M. et al. Conditional immortalization of human B cells by CD40 ligation. PLoS One 3, (2008).","DOI":"10.1371\/journal.pone.0001464"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32772-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T14:07:03Z","timestamp":1666620423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32772-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32772"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32772-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-846197\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5586"}}